Global healthcare investing

Modern healthcare venture capital investing requires a global scope. SR Ones geographic reach extends not only across North American and European markets, but also further afield in emerging economies.

Entrepreneurial venture creation and growth

SR One has assembled a team with a broad spectrum of relevant backgrounds whose collective insight benefits portfolio company management teams in the formation of companies, in the Board Room, and throughout transactions.

Innovative Science for patient benefit

Enabling people to do more, feel better, and live longer, by investing in healthcare companies pursuing innovative, breakthrough science that will impact patient care

In Memoriam: Brenda D. Gavin, DVM

Brenda was President of S.R. One, Limited from 1999 to 2002 and a general partner of EuclidSR Partners. She left to cofound Quaker Partners. Brenda was honored with the 2005 Alliance of Women Entrepreneurs Iris Newman Award, 2009 Early Stage East Sal Buccieri Venture Impact Award, and 2010 Pennsylvania Biotechnology Association Hubert J.P. Schoemaker Leadership Award.<

Latest News

Portfolio

  1. Addex Therapeutics
  2. Aileron Therapeutics
  3. Applied Genetic Technologies Corporation
  4. Asceneuron
  5. Atopix Therapeutics Limited
  6. Atox Bio Ltd
  7. Avhana Health
  8. Bicycle Therapeutics Limited
  9. Bird Rock Bio
  10. CalciMedica, Inc.
  11. CoNCERT Pharmaceuticals Inc.
  12. Constellation Pharmaceuticals
  13. CRISPR Therapeutics
  14. Decibel Therapeutics
  15. Dicerna Pharmaceuticals
  16. eFFECTOR Therapeutics
  17. F-star
  18. Genocea Biosciences
  19. Gladius Pharmaceuticals
  20. HTG Molecular
  21. IlluminOss Medical Ltd
  22. Macrolide Pharmaceuticals
  23. Mission Therapeutics
  24. Morphic Therapeutic
  25. Navitor Pharmaceuticals
  26. Nimbus Therapeutics
  27. Principia BioPharma Inc.
  28. Progenitor Therapeutics
  29. Progyny, Inc
  30. Propeller Health
  31. PsiOxus Therapeutics, Ltd
  32. Puridify Limited
  33. RaNA Therapeutics
  34. River Vision Development Corporation
  35. SCYNEXIS, Inc.
  36. Second Genome, Inc.
  37. Spero Therapeutics
  38. Thrasos Therapeutics
  39. Tioma Therapeutics
  40. True North Therapeutics, Inc.
  41. VHsquared Ltd
  42. ZappRx, Inc.